Eton Pharmaceuticals, Inc. (ETON) Gross profit 2019–2025
Eton Pharmaceuticals, Inc. (ETON) annual gross profit history from SEC filings — each fiscal year as reported.
$42.7MFY2025 · since FY2019: $506,000 → $42.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $42.7M | +82.6% |
| FY2024 | $23.4M | +11.2% |
| FY2023 | $21.1M | +47.1% |
| FY2022 | $14.3M | -24.7% |
| FY2021 | $19.0M | +4887.2% |
| FY2020 | -$397,000 | -178.5% |
| FY2019 | $506,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross marginETON Operating incomeETON Operating marginETON Operating cash flowETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →